Skip to main content

Table 1 Characteristics of 21 patients with carbapenemase-producing P. aeruginosa

From: Molecular surveillance of carbapenemase-producing Pseudomonas aeruginosa at three medical centres in Cologne, Germany

Patient characteristics (n = 21)Value
Age (years)
 mean62
 range20; 80
Sex
 male16 (76.2%)
Source of first positive specimen
 respiratory tract7 (33.3%)
 urine5 (23.8%)
 screening (rectum)5 (23.8%)
 wound2 (9.5%)
 other2 (9.5%)
Infection/colonization with CPPA
 hospital-acquired15 (71.4%)
 community-acquired6 (28.6%)
Day of acquisition during hospital stay (hospital-acquired CPPA only; n = 15)
 mean19
 range8; 82
Medical centres
 tertiary care20 (95.2%)
 secondary care1 (4.8%)
 children hospital0 (0%)
Ward type
 ICU14 (66.7%)
 general ward7 (33.3%)
Medical departments
 surgery11 (52.4%)
 internal medicine8 (38.1%)
 others2 (9.5%)
Hospital-acquired infection (CDC)
 pneumonia5 (23.8%)
 urinary tract2 (9.5%)
 skin infection2 (9.5%)
Antipseudomonal antibiotic therapya15 (71.4%)
Surgerya15 (71.4%)
Nonsurgical interventiona19 (90.5%)
Dialysisa6 (28.6%)
Mechanical ventilationa16 (76.2%)
Woundsa15 (71.4%)
Central linea17 (80.1%)
Urinary cathetera18 (85.7%)
  1. awithin a maximal interval of 7 days before first isolation of CPPA